Bafna Pharmaceuticals Stock Hits Upper Circuit Limit with Intraday High of Rs 176.33

Bafna Pharmaceuticals Ltd, a microcap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today as it hit its upper circuit limit. The stock reached an intraday high of Rs 176.33, reflecting a 5% increase from its previous close. The last traded price (LTP) stands at Rs 167.94, marking a change of Rs 7.99 or 5.0% for the day.
Despite this positive movement, the stock has underperformed its sector by 2.48% and has experienced a trend reversal after seven consecutive days of gains. The stock opened with a gap up, indicating strong initial interest, but has traded within a wide range of Rs 16.79 throughout the day, with a low of Rs 159.54.

Total traded volume reached approximately 0.11854 lakh shares, resulting in a turnover of Rs 0.199 crore. Notably, Bafna Pharmaceuticals is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a robust position in the market.

In summary, Bafna Pharmaceuticals has demonstrated notable performance today, hitting its upper circuit limit while navigating a volatile trading environment.